Guided Therapeutics (GTHP) Goodwill & Intangibles (2010 - 2011)
Guided Therapeutics' (GTHP) quarterly Goodwill & Intangibles came in at $409000.0 in Q2 2011, up 36.79% quarter-over-quarter from $299000.0 in Q4 2010.
Analysis
Guided Therapeutics (GTHP) Goodwill & Intangibles (2010 - 2011) Analysis & Trends
Guided Therapeutics has disclosed Goodwill & Intangibles across 2 years of filings, most recently posting $409000.0 for Q2 2011.
- In Q2 2011, Goodwill & Intangibles changed N/A year-over-year to $409000.0; the TTM figure through Jun 2011 stood at $409000.0 (changed N/A YoY), while the FY2010 annual figure was $299000.0, changed N/A from the prior year.
- Goodwill & Intangibles came in at $409000.0 for Q2 2011 at Guided Therapeutics, up from $299000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $409000.0 in Q2 2011 to a low of $299000.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - |